GlassScriptPhysician profile
Anton Kurdin
NPI 1336757970
$144,731.62
in general payments reported to CMS, 2019-2025
8 companies · $68K in 2025
The $68K reported for 2025 was more than what 90% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $115 · 2021: $494 · 2022: $5,381 · 2023: $3,665 · 2024: $68K · 2025: $68K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $57K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $47K · Travel and Lodging: $27K · Food and Beverage: $8,230.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $57,020.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $46,925.00 |
| Travel and Lodging | $26,565.64 |
| Food and Beverage | $8,230.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $139,716.11 | 2021-2025 | Journey II, Real Intelligence, Legion Revision |
| Stryker Corporation | $1,914.79 | 2020-2024 | Mako, Accolade |
| Medacta USA, INC. | $1,382.99 | 2022-2025 | Gmk Sphere, Gmk Revision |
| Uoc USA INC | $1,205.79 | 2025 | U2, Resolve |
| Zimmer Biomet Holdings, INC. | $201.41 | 2021-2023 | Oss Orthopedic Salvage System |
| Osteoremedies, LLC | $176.05 | 2025 | Remedy Spectrum Gv Spacer, Remedy Spacer, Osteoboost Select 5cc |
| Depuy Synthes Sales INC. | $101.83 | 2023 | Attune |
| Ethicon US, LLC | $32.65 | 2025 | Stratafix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anton Kurdin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.